Disc Medicine (IRON) Other Working Capital Changes (2020 - 2026)
Disc Medicine (IRON) reported Other Working Capital Changes of -$168000.0 for Q1 2026, down 138.62% year-over-year from $435000.0 in Q1 2025, and down 112.16% quarter-over-quarter from $1.4 million in Q4 2025.
Disc Medicine (IRON) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has 7 years of Other Working Capital Changes data on file, last reported at -$168000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$168000.0, down 138.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.3 million (up 574.56% YoY), and the FY2025 annual result was $8177.0, down 35.88% from the prior year.
- Other Working Capital Changes slipped to -$168000.0 in Q1 2026 per IRON's latest filing, from $1.4 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $7.5 million in Q2 2025 and troughed at -$3.2 million in Q1 2022.
- A 5-year average of $469143.1 and a median of $12308.0 in 2024 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 3588.24% in 2024, then soared 62450.2% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at -$4000.0 in 2022, then soared by 950.0% to $34000.0 in 2023, then tumbled by 3588.24% to -$1.2 million in 2024, then surged by 216.53% to $1.4 million in 2025, then plunged by 112.16% to -$168000.0 in 2026.
- Business Quant data shows IRON's Other Working Capital Changes at -$168000.0 in Q1 2026, $1.4 million in Q4 2025, and -$371000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Disc Medicine | 2.73 Bn | 2.00 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,000.00 |
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | -371,000.00 |
| Sep 30, 2025 | -371,000.00 |
| Jun 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 7.48 Mn |
| Mar 31, 2025 | 435,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | -1.19 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | 12,664.00 |
| Sep 30, 2024 | 12,664.00 |
| Jun 30, 2024 | 11,952.00 |
| Jun 30, 2024 | 11,952.00 |
| Mar 31, 2024 | 1,244.00 |
| Mar 31, 2024 | 1,244.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |